CBR1 Human (+)-schisandrin B multiple interactions ISO Cbr1 (Rattus norvegicus) 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CBR1 mRNA] CTD PMID:31150632 CBR1 Human (1->4)-beta-D-glucan multiple interactions ISO Cbr1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CBR1 mRNA CTD PMID:36331819 CBR1 Human 1,2-naphthoquinone multiple interactions EXP 6480464 [S-Nitrosoglutathione binds to CBR1 protein] promotes the reaction [CBR1 protein results in increased metabolism of 1 and 2-naphthoquinone] CTD PMID:23295225 CBR1 Human 1,4-dithiothreitol multiple interactions EXP 6480464 Dithiothreitol inhibits the reaction [S-Nitrosoglutathione inhibits the reaction [CBR1 protein results in increased reduction of S-Nitrosoglutathione]] CTD PMID:21256830 CBR1 Human 1,4-naphthoquinone multiple interactions EXP 6480464 [S-Nitrosoglutathione binds to CBR1 protein] inhibits the reaction [CBR1 protein results in increased metabolism of 1 and 4-naphthoquinone] CTD PMID:23295225 CBR1 Human 13-dihydrodaunorubicin multiple interactions EXP 6480464 [[Curcumin binds to and results in decreased activity of CBR1 protein] which results in decreased reduction of Daunorubicin] which results in decreased chemical synthesis of daunorubicinol more ... CTD PMID:20670211 and PMID:25541467 CBR1 Human 17alpha-ethynylestradiol affects expression ISO Cbr1 (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of CBR1 mRNA CTD PMID:17555576 CBR1 Human 17alpha-ethynylestradiol multiple interactions ISO Cbr1 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CBR1 mRNA CTD PMID:17942748 CBR1 Human 17alpha-ethynylestradiol increases expression ISO Cbr1 (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of CBR1 mRNA CTD PMID:17942748 CBR1 Human 17beta-estradiol multiple interactions ISO Cbr1 (Rattus norvegicus) 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of CBR1 mRNA CTD PMID:26496021 CBR1 Human 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Cbr1 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of CBR1 mRNA and [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CBR1 mRNA CTD PMID:16214954 and PMID:17942748 CBR1 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Cbr1 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of CBR1 protein CTD PMID:19492234 CBR1 Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Cbr1 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of CBR1 mRNA CTD PMID:33387578 CBR1 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Cbr1 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin affects the expression of CBR1 mRNA CTD PMID:22298810 CBR1 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Cbr1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of CBR1 mRNA CTD PMID:20702594 and PMID:21570461 CBR1 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Cbr1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of CBR1 mRNA CTD PMID:18796159 and PMID:19933214 CBR1 Human 2,4-dinitrotoluene affects expression ISO Cbr1 (Rattus norvegicus) 6480464 2 and 4-dinitrotoluene affects the expression of CBR1 mRNA CTD PMID:21346803 CBR1 Human 2,6-dimethoxyphenol multiple interactions EXP 6480464 [pyrogallol 1 more ... CTD PMID:38598786 CBR1 Human 2,6-dinitrotoluene affects expression ISO Cbr1 (Rattus norvegicus) 6480464 2 and 6-dinitrotoluene affects the expression of CBR1 mRNA CTD PMID:21346803 CBR1 Human 2-acetamidofluorene increases expression ISO Cbr1 (Mus musculus) 6480464 2-Acetylaminofluorene results in increased expression of CBR1 mRNA CTD PMID:21607683 CBR1 Human 2-amino-14,16-dimethyloctadecan-3-ol decreases expression EXP 6480464 2-amino-14 and 16-dimethyloctadecan-3-ol results in decreased expression of CBR1 protein CTD PMID:32044396 CBR1 Human 2-hydroxypropanoic acid decreases expression EXP 6480464 Lactic Acid results in decreased expression of CBR1 mRNA CTD PMID:30851411 CBR1 Human 2-methoxyethanol increases expression ISO Cbr1 (Rattus norvegicus) 6480464 methyl cellosolve results in increased expression of CBR1 protein CTD PMID:15928459 CBR1 Human 3,3',4,4',5-pentachlorobiphenyl affects expression ISO Cbr1 (Mus musculus) 6480464 3 more ... CTD PMID:20702594 CBR1 Human 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one multiple interactions EXP 6480464 Ethacrynic Acid inhibits the reaction [CBR1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] more ... CTD PMID:11306090 CBR1 Human 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases metabolic processing EXP 6480464 CBR1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone CTD PMID:11306090 CBR1 Human 4-amino-2,6-dinitrotoluene affects expression ISO Cbr1 (Rattus norvegicus) 6480464 4-amino-2 and 6-dinitrotoluene affects the expression of CBR1 mRNA CTD PMID:21346803 CBR1 Human 4-Benzoylpyridine multiple interactions EXP 6480464 [S-Nitrosoglutathione binds to CBR1 protein] inhibits the reaction [CBR1 protein results in increased metabolism of 4-benzoylpyridine] CTD PMID:23295225 CBR1 Human 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression ISO Cbr1 (Rattus norvegicus) 6480464 Omeprazole affects the expression of CBR1 mRNA CTD PMID:19483382 CBR1 Human 6-propyl-2-thiouracil affects expression ISO Cbr1 (Rattus norvegicus) 6480464 Propylthiouracil affects the expression of CBR1 mRNA CTD PMID:19483382 CBR1 Human 6-propyl-2-thiouracil increases expression ISO Cbr1 (Rattus norvegicus) 6480464 Propylthiouracil results in increased expression of CBR1 mRNA CTD PMID:24780913 and PMID:30047161 CBR1 Human 9,10-phenanthroquinone multiple interactions EXP 6480464 [CBR1 protein co-treated with NADP] results in increased reduction of and affects the activity of 9 more ... CTD PMID:21910479 and PMID:23295225 CBR1 Human 9,10-phenanthroquinone increases metabolic processing EXP 6480464 CBR1 protein results in increased metabolism of 9 and 10-phenanthrenequinone CTD PMID:29108775 CBR1 Human actinomycin D multiple interactions EXP 6480464 [Dactinomycin co-treated with nutlin 3] results in increased secretion of CBR1 protein CTD PMID:38460933 CBR1 Human Aloe emodin decreases activity EXP 6480464 aloe emodin results in decreased activity of CBR1 protein CTD PMID:35065925 CBR1 Human alpha-Zearalanol multiple interactions ISO Cbr1 (Rattus norvegicus) 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of CBR1 mRNA CTD PMID:35163327 CBR1 Human amiodarone affects expression ISO Cbr1 (Rattus norvegicus) 6480464 Amiodarone affects the expression of CBR1 mRNA CTD PMID:19483382 CBR1 Human amitrole increases expression ISO Cbr1 (Rattus norvegicus) 6480464 Amitrole results in increased expression of CBR1 mRNA CTD PMID:30047161 CBR1 Human ammonium chloride affects expression ISO Cbr1 (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of CBR1 mRNA CTD PMID:16483693 CBR1 Human andrographolide multiple interactions ISO Cbr1 (Mus musculus) 6480464 [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of CBR1 mRNA CTD PMID:19737545 CBR1 Human antimonite multiple interactions EXP 6480464 [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of CBR1 mRNA CTD PMID:32076005 CBR1 Human antimycin A decreases expression EXP 6480464 Antimycin A results in decreased expression of CBR1 mRNA CTD PMID:33512557 CBR1 Human aristolochic acid A increases expression EXP 6480464 aristolochic acid I results in increased expression of CBR1 protein CTD PMID:33212167 CBR1 Human arsenite(3-) multiple interactions EXP 6480464 [sodium arsenite results in increased abundance of arsenite] which results in increased expression of CBR1 mRNA more ... CTD PMID:32076005 and PMID:32406909 CBR1 Human arsenous acid increases expression EXP 6480464 Arsenic Trioxide results in increased expression of CBR1 mRNA CTD PMID:22719067 CBR1 Human arsenous acid decreases response to substance EXP 6480464 CBR1 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:22719067 CBR1 Human atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of CBR1 mRNA CTD PMID:22378314 CBR1 Human benzbromarone affects expression ISO Cbr1 (Rattus norvegicus) 6480464 Benzbromarone affects the expression of CBR1 mRNA CTD PMID:19483382 CBR1 Human benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of CBR1 mRNA and Benzo(a)pyrene results in increased expression of CBR1 protein CTD PMID:22531821 CBR1 Human benzo[a]pyrene decreases methylation EXP 6480464 Benzo(a)pyrene results in decreased methylation of CBR1 exon CTD PMID:27901495 CBR1 Human benzo[a]pyrene multiple interactions ISO Cbr1 (Mus musculus) 6480464 [lipopolysaccharide and E coli O55-B5 co-treated with Benzo(a)pyrene] affects the expression of CBR1 mRNA CTD PMID:28987381 CBR1 Human benzo[a]pyrene increases expression ISO Cbr1 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of CBR1 mRNA CTD PMID:19770486 more ... CBR1 Human beta-naphthoflavone increases expression EXP 6480464 beta-Naphthoflavone results in increased expression of CBR1 mRNA CTD PMID:17569794 and PMID:19737606 CBR1 Human beta-naphthoflavone multiple interactions ISO Cbr1 (Mus musculus) 6480464 [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of CBR1 mRNA CTD PMID:19737545 CBR1 Human bexarotene increases expression ISO Cbr1 (Rattus norvegicus) 6480464 Bexarotene results in increased expression of CBR1 mRNA CTD PMID:16648578 CBR1 Human bisphenol A multiple interactions ISO Cbr1 (Rattus norvegicus) 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of CBR1 mRNA and [bisphenol A co-treated with Testosterone] results in increased expression of CBR1 mRNA CTD PMID:26496021 CBR1 Human bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CBR1 protein CTD PMID:37567409 CBR1 Human bisphenol A increases expression ISO Cbr1 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of CBR1 mRNA CTD PMID:25181051 CBR1 Human bisphenol AF increases expression EXP 6480464 bisphenol AF results in increased expression of CBR1 protein CTD PMID:34186270 CBR1 Human Bisphenol B increases expression EXP 6480464 bisphenol B results in increased expression of CBR1 protein CTD PMID:34186270 CBR1 Human bisphenol F increases expression EXP 6480464 bisphenol F results in increased expression of CBR1 protein CTD PMID:34186270 CBR1 Human butylated hydroxyanisole increases expression EXP 6480464 Butylated Hydroxyanisole results in increased expression of CBR1 mRNA and Butylated Hydroxyanisole results in increased expression of CBR1 protein CTD PMID:23247010 CBR1 Human captan increases expression ISO Cbr1 (Mus musculus) 6480464 Captan results in increased expression of CBR1 mRNA CTD PMID:31558096 CBR1 Human carbamazepine affects expression EXP 6480464 Carbamazepine affects the expression of CBR1 mRNA CTD PMID:24752500 CBR1 Human carbon nanotube decreases expression ISO Cbr1 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 and PMID:25620056 CBR1 Human CGP 52608 multiple interactions EXP 6480464 CGP 52608 promotes the reaction [RORA protein binds to CBR1 gene] CTD PMID:28238834 CBR1 Human chenodeoxycholic acid multiple interactions EXP 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA and [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA CTD PMID:32152650 CBR1 Human chloroprene increases expression ISO Cbr1 (Mus musculus) 6480464 Chloroprene results in increased expression of CBR1 mRNA CTD PMID:23125180 CBR1 Human ciprofibrate increases expression ISO Cbr1 (Mus musculus) 6480464 ciprofibrate results in increased expression of CBR1 mRNA CTD PMID:12771043 CBR1 Human cisplatin multiple interactions EXP 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of CBR1 mRNA CTD PMID:27392435 CBR1 Human clofibrate affects expression ISO Cbr1 (Rattus norvegicus) 6480464 Clofibrate affects the expression of CBR1 mRNA CTD PMID:19483382 CBR1 Human Clofop increases reduction EXP 6480464 CBR1 protein results in increased reduction of fenofibric acid CTD PMID:27599626 CBR1 Human coumarin increases expression ISO Cbr1 (Rattus norvegicus) 6480464 coumarin results in increased expression of CBR1 mRNA CTD PMID:18480146 CBR1 Human coumestrol increases expression EXP 6480464 Coumestrol results in increased expression of CBR1 mRNA CTD PMID:19167446 CBR1 Human Cuprizon increases expression ISO Cbr1 (Rattus norvegicus) 6480464 Cuprizone results in increased expression of CBR1 mRNA CTD PMID:26577399 CBR1 Human curcumin multiple interactions EXP 6480464 [[Curcumin binds to and results in decreased activity of CBR1 protein] which results in decreased reduction of Daunorubicin] which results in decreased chemical synthesis of daunorubicinol more ... CTD PMID:25541467 CBR1 Human cyclosporin A decreases expression ISO Cbr1 (Mus musculus) 6480464 Cyclosporine results in decreased expression of CBR1 mRNA CTD PMID:19770486 CBR1 Human cyclosporin A multiple interactions EXP 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA CTD PMID:32152650 CBR1 Human cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of CBR1 mRNA CTD PMID:20106945 and PMID:25562108 CBR1 Human daunorubicin increases metabolic processing EXP 6480464 CBR1 protein results in increased metabolism of Daunorubicin and CBR1 results in increased metabolism of Daunorubicin CTD PMID:20670211 and PMID:30849340 CBR1 Human daunorubicin increases reduction EXP 6480464 CBR1 protein results in increased reduction of Daunorubicin CTD PMID:18579125 and PMID:25541467 CBR1 Human daunorubicin decreases metabolic processing EXP 6480464 CBR1 gene SNP results in decreased metabolism of Daunorubicin CTD PMID:19204081 CBR1 Human daunorubicin multiple interactions EXP 6480464 8-prenylnaringenin inhibits the reaction [CBR1 protein results in increased metabolism of Daunorubicin] more ... CTD PMID:20670211 more ... CBR1 Human deguelin decreases expression EXP 6480464 deguelin results in decreased expression of CBR1 mRNA CTD PMID:33512557 CBR1 Human deoxycholic acid multiple interactions EXP 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA and [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA CTD PMID:32152650 CBR1 Human dexamethasone decreases expression ISO Cbr1 (Mus musculus) 6480464 Dexamethasone results in decreased expression of CBR1 mRNA CTD PMID:22733784 CBR1 Human dextran sulfate decreases expression ISO Cbr1 (Mus musculus) 6480464 Dextran Sulfate results in decreased expression of CBR1 protein CTD PMID:35999755 CBR1 Human diarsenic trioxide decreases response to substance EXP 6480464 CBR1 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:22719067 CBR1 Human diarsenic trioxide increases expression EXP 6480464 Arsenic Trioxide results in increased expression of CBR1 mRNA CTD PMID:22719067 CBR1 Human dibenzofurans increases expression ISO Cbr1 (Mus musculus) 6480464 Dibenzofurans results in increased expression of CBR1 mRNA CTD PMID:34254344 CBR1 Human Dibutyl phosphate affects expression EXP 6480464 di-n-butylphosphoric acid affects the expression of CBR1 mRNA CTD PMID:37042841 CBR1 Human dibutyl phthalate decreases expression ISO Cbr1 (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of CBR1 mRNA CTD PMID:17361019 and PMID:21266533 CBR1 Human dibutyl phthalate decreases expression ISO Cbr1 (Rattus norvegicus) 6480464 Dibutyl Phthalate results in decreased expression of CBR1 mRNA CTD PMID:21266533 CBR1 Human diclofenac affects expression EXP 6480464 Diclofenac affects the expression of CBR1 mRNA CTD PMID:24752500 CBR1 Human diethyl maleate increases expression ISO Cbr1 (Mus musculus) 6480464 diethyl maleate results in increased expression of CBR1 mRNA CTD PMID:25270620 CBR1 Human dioxygen multiple interactions EXP 6480464 3 more ... CTD PMID:24975222 CBR1 Human dioxygen multiple interactions ISO Cbr1 (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CBR1 mRNA CTD PMID:30529165 CBR1 Human dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of CBR1 mRNA and Oxygen deficiency results in increased expression of CBR1 protein CTD PMID:24975222 CBR1 Human dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate multiple interactions EXP 6480464 [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of CBR1 mRNA CTD PMID:32076005 CBR1 Human diquat increases expression ISO Cbr1 (Mus musculus) 6480464 Diquat results in increased expression of CBR1 mRNA CTD PMID:36851058 CBR1 Human diuron decreases expression ISO Cbr1 (Rattus norvegicus) 6480464 Diuron results in decreased expression of CBR1 mRNA CTD PMID:21551480 CBR1 Human dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CBR1 mRNA CTD PMID:27188386 CBR1 Human doxorubicin affects reduction EXP 6480464 CBR1 protein affects the reduction of Doxorubicin CTD PMID:18635746 CBR1 Human doxorubicin multiple interactions EXP 6480464 [resveratrol results in decreased activity of CBR1 protein] which affects the susceptibility to Doxorubicin CTD PMID:24064738 CBR1 Human doxorubicin increases response to substance ISO Cbr1 (Mus musculus) 6480464 CBR1 protein results in increased susceptibility to Doxorubicin CTD PMID:11016643 and PMID:14583452 CBR1 Human doxorubicin increases reduction EXP 6480464 CBR1 protein results in increased reduction of Doxorubicin CTD PMID:18755171 CBR1 Human doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of CBR1 protein CTD PMID:18755171 CBR1 Human doxorubicin decreases metabolic processing EXP 6480464 CBR1 gene SNP results in decreased metabolism of Doxorubicin CTD PMID:19204081 CBR1 Human emodin decreases activity EXP 6480464 Emodin results in decreased activity of CBR1 protein CTD PMID:35065925 CBR1 Human endosulfan increases expression ISO Cbr1 (Rattus norvegicus) 6480464 Endosulfan results in increased expression of CBR1 mRNA CTD PMID:29391264 CBR1 Human etacrynic acid multiple interactions EXP 6480464 Ethacrynic Acid inhibits the reaction [CBR1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] CTD PMID:11306090 CBR1 Human ethanol affects expression ISO Cbr1 (Mus musculus) 6480464 Ethanol affects the expression of CBR1 mRNA CTD PMID:30319688 CBR1 Human ethanol increases expression ISO Cbr1 (Mus musculus) 6480464 Ethanol results in increased expression of CBR1 mRNA CTD PMID:30319688 CBR1 Human fenpyroximate decreases expression EXP 6480464 fenpyroximate results in decreased expression of CBR1 mRNA CTD PMID:33512557 CBR1 Human fenthion increases expression ISO Cbr1 (Mus musculus) 6480464 Fenthion results in increased expression of CBR1 mRNA CTD PMID:34813904 CBR1 Human flutamide increases expression ISO Cbr1 (Rattus norvegicus) 6480464 Flutamide results in increased expression of CBR1 mRNA CTD PMID:24136188 CBR1 Human folpet increases expression ISO Cbr1 (Mus musculus) 6480464 folpet results in increased expression of CBR1 mRNA CTD PMID:31558096 CBR1 Human FR900359 increases phosphorylation EXP 6480464 FR900359 results in increased phosphorylation of CBR1 protein CTD PMID:37730182 CBR1 Human Frangulin A decreases activity EXP 6480464 frangulin A results in decreased activity of CBR1 protein CTD PMID:35065925 CBR1 Human Frangulin B decreases activity EXP 6480464 frangulin B results in decreased activity of CBR1 protein CTD PMID:35065925 CBR1 Human furan increases expression ISO Cbr1 (Mus musculus) 6480464 furan results in increased expression of CBR1 mRNA CTD PMID:24183702 CBR1 Human furan increases expression ISO Cbr1 (Rattus norvegicus) 6480464 furan results in increased expression of CBR1 mRNA CTD PMID:25539665 CBR1 Human furfural multiple interactions EXP 6480464 [pyrogallol 1 and 3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of CBR1 protein CTD PMID:38598786 CBR1 Human genistein increases expression EXP 6480464 Genistein results in increased expression of CBR1 mRNA CTD PMID:16705744 CBR1 Human genistein increases expression ISO Cbr1 (Mus musculus) 6480464 Genistein results in increased expression of CBR1 mRNA CTD PMID:34942354 CBR1 Human genistein multiple interactions ISO Cbr1 (Mus musculus) 6480464 [mono-(2-ethylhexyl)phthalate co-treated with Genistein] results in increased expression of CBR1 mRNA CTD PMID:34942354 CBR1 Human genistein multiple interactions EXP 6480464 [Genistein co-treated with NADP] binds to CBR1 protein CTD PMID:25526675 CBR1 Human glycochenodeoxycholic acid multiple interactions EXP 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA and [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA CTD PMID:32152650 CBR1 Human glycocholic acid multiple interactions EXP 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA and [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA CTD PMID:32152650 CBR1 Human glycodeoxycholic acid multiple interactions EXP 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA and [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA CTD PMID:32152650 CBR1 Human griseofulvin affects expression ISO Cbr1 (Mus musculus) 6480464 Griseofulvin affects the expression of CBR1 mRNA CTD PMID:12735108 CBR1 Human hexane-2,3-dione increases reduction EXP 6480464 CBR1 protein results in increased reduction of 2 and 3-hexanedione CTD PMID:25541467 and PMID:30849340 CBR1 Human hexane-2,3-dione multiple interactions EXP 6480464 8-prenylnaringenin inhibits the reaction [CBR1 protein results in increased reduction of 2 more ... CTD PMID:23295225 more ... CBR1 Human hydrazine increases expression ISO Cbr1 (Mus musculus) 6480464 hydrazine results in increased expression of CBR1 mRNA CTD PMID:15282401 CBR1 Human indometacin increases expression ISO Cbr1 (Rattus norvegicus) 6480464 Indomethacin results in increased expression of CBR1 mRNA CTD PMID:18299717 CBR1 Human inulin multiple interactions ISO Cbr1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CBR1 mRNA CTD PMID:36331819 CBR1 Human isatin multiple interactions EXP 6480464 [S-Nitrosoglutathione binds to CBR1 protein] promotes the reaction [CBR1 protein results in increased metabolism of Isatin] CTD PMID:23295225 CBR1 Human Isoxanthohumol multiple interactions EXP 6480464 isoxanthohumol inhibits the reaction [CBR1 protein results in increased metabolism of Daunorubicin] more ... CTD PMID:30849340 CBR1 Human Isoxanthohumol decreases activity EXP 6480464 isoxanthohumol results in decreased activity of CBR1 protein CTD PMID:35065925 CBR1 Human ivermectin decreases expression EXP 6480464 Ivermectin results in decreased expression of CBR1 protein CTD PMID:32959892 CBR1 Human L-1,4-dithiothreitol multiple interactions EXP 6480464 Dithiothreitol inhibits the reaction [S-Nitrosoglutathione inhibits the reaction [CBR1 protein results in increased reduction of S-Nitrosoglutathione]] CTD PMID:21256830 CBR1 Human L-ethionine affects expression ISO Cbr1 (Rattus norvegicus) 6480464 Ethionine affects the expression of CBR1 mRNA CTD PMID:19483382 CBR1 Human lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of CBR1 mRNA CTD PMID:38568856 CBR1 Human leflunomide increases expression ISO Cbr1 (Rattus norvegicus) 6480464 Leflunomide results in increased expression of CBR1 mRNA CTD PMID:24136188 CBR1 Human lipopolysaccharide multiple interactions EXP 6480464 CBR1 protein modified form inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] more ... CTD PMID:25818598 CBR1 Human m-xylene increases expression ISO Cbr1 (Rattus norvegicus) 6480464 3-xylene results in increased expression of CBR1 mRNA CTD PMID:12815608 CBR1 Human menadione increases metabolic processing EXP 6480464 CBR1 protein results in increased metabolism of Vitamin K 3 CTD PMID:19061875 CBR1 Human menadione multiple interactions EXP 6480464 [S-Nitrosoglutathione binds to CBR1 protein] inhibits the reaction [CBR1 protein results in increased metabolism of Vitamin K 3] and Vitamin K 3 inhibits the reaction [CBR1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] CTD PMID:11306090 and PMID:23295225 CBR1 Human methamphetamine decreases expression ISO Cbr1 (Rattus norvegicus) 6480464 Methamphetamine results in decreased expression of CBR1 mRNA CTD PMID:15644446 CBR1 Human methimazole increases expression ISO Cbr1 (Rattus norvegicus) 6480464 Methimazole results in increased expression of CBR1 mRNA CTD PMID:30047161 CBR1 Human methylmercury chloride decreases expression EXP 6480464 methylmercuric chloride results in decreased expression of CBR1 mRNA CTD PMID:27188386 CBR1 Human microcystin-LR increases expression ISO Cbr1 (Mus musculus) 6480464 cyanoginosin LR results in increased expression of CBR1 mRNA CTD PMID:17654400 CBR1 Human mono(2-ethylhexyl) phthalate multiple interactions ISO Cbr1 (Mus musculus) 6480464 [mono-(2-ethylhexyl)phthalate co-treated with Genistein] results in increased expression of CBR1 mRNA CTD PMID:34942354 CBR1 Human monosodium L-glutamate increases activity ISO Cbr1 (Mus musculus) 6480464 Sodium Glutamate results in increased activity of CBR1 protein CTD PMID:25473020 CBR1 Human N-methyl-N-nitrosourea increases expression ISO Cbr1 (Rattus norvegicus) 6480464 Methylnitrosourea results in increased expression of CBR1 mRNA CTD PMID:16525678 CBR1 Human N-nitrosodiethylamine increases expression ISO Cbr1 (Mus musculus) 6480464 Diethylnitrosamine results in increased expression of CBR1 mRNA CTD PMID:12771043 and PMID:21607683 CBR1 Human N-nitrosodiethylamine increases expression ISO Cbr1 (Rattus norvegicus) 6480464 Diethylnitrosamine results in increased expression of CBR1 mRNA CTD PMID:19638242 CBR1 Human N-nitrosomorpholine increases expression ISO Cbr1 (Rattus norvegicus) 6480464 N-nitrosomorpholine results in increased expression of CBR1 mRNA CTD PMID:19716841 CBR1 Human NADP zwitterion multiple interactions EXP 6480464 [CBR1 protein co-treated with NADP] results in increased reduction of and affects the activity of 9 more ... CTD PMID:21910479 more ... CBR1 Human NADP(+) multiple interactions EXP 6480464 [CBR1 protein co-treated with NADP] results in increased reduction of and affects the activity of 9 more ... CTD PMID:21910479 more ... CBR1 Human naphthalenes multiple interactions EXP 6480464 [CBR1 protein co-treated with NADP] results in increased reduction of and affects the activity of Naphthalenes CTD PMID:21910479 CBR1 Human naphthalenes increases expression ISO Cbr1 (Rattus norvegicus) 6480464 Naphthalenes results in increased expression of CBR1 protein CTD PMID:17337753 CBR1 Human nefazodone multiple interactions EXP 6480464 [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA CTD PMID:32152650 CBR1 Human nefazodone increases expression ISO Cbr1 (Rattus norvegicus) 6480464 nefazodone results in increased expression of CBR1 mRNA CTD PMID:24136188 CBR1 Human nimesulide increases expression ISO Cbr1 (Rattus norvegicus) 6480464 nimesulide results in increased expression of CBR1 mRNA CTD PMID:24136188 CBR1 Human Nutlin-3 multiple interactions EXP 6480464 [Dactinomycin co-treated with nutlin 3] results in increased secretion of CBR1 protein CTD PMID:38460933 CBR1 Human omeprazole affects expression ISO Cbr1 (Rattus norvegicus) 6480464 Omeprazole affects the expression of CBR1 mRNA CTD PMID:19483382 CBR1 Human oxcarbazepine increases reduction EXP 6480464 CBR1 protein results in increased reduction of oxcarbazepine CTD PMID:25063510 CBR1 Human paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of CBR1 mRNA CTD PMID:22230336 and PMID:29067470 CBR1 Human paracetamol affects expression ISO Cbr1 (Rattus norvegicus) 6480464 Acetaminophen affects the expression of CBR1 mRNA CTD PMID:18246545 CBR1 Human paracetamol decreases expression ISO Cbr1 (Rattus norvegicus) 6480464 Acetaminophen results in decreased expression of CBR1 mRNA CTD PMID:18246545 CBR1 Human parathion increases expression ISO Cbr1 (Mus musculus) 6480464 Parathion results in increased expression of CBR1 mRNA CTD PMID:34813904 CBR1 Human pentachlorophenol increases expression ISO Cbr1 (Mus musculus) 6480464 Pentachlorophenol results in increased expression of CBR1 mRNA CTD PMID:23892564 CBR1 Human perfluorohexanesulfonic acid increases expression ISO Cbr1 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in increased expression of CBR1 mRNA CTD PMID:37995155 CBR1 Human perfluorooctane-1-sulfonic acid multiple interactions ISO Cbr1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CBR1 mRNA more ... CTD PMID:36331819 CBR1 Human perfluorooctanoic acid multiple interactions ISO Cbr1 (Rattus norvegicus) 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of CBR1 mRNA CTD PMID:35163327 CBR1 Human perfluorooctanoic acid increases expression ISO Cbr1 (Rattus norvegicus) 6480464 perfluorooctanoic acid results in increased expression of CBR1 mRNA CTD PMID:19162173 CBR1 Human phenobarbital multiple interactions ISO Cbr1 (Mus musculus) 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of CBR1 mRNA] CTD PMID:19482888 CBR1 Human phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of CBR1 protein CTD PMID:35881160 CBR1 Human phenobarbital increases expression ISO Cbr1 (Mus musculus) 6480464 Phenobarbital results in increased expression of CBR1 mRNA and Phenobarbital results in increased expression of CBR1 protein CTD PMID:19482888 more ... CBR1 Human phorbol 13-acetate 12-myristate multiple interactions EXP 6480464 CBR1 protein modified form inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL1B mRNA] more ... CTD PMID:25818598 CBR1 Human phorone affects expression ISO Cbr1 (Rattus norvegicus) 6480464 phorone affects the expression of CBR1 mRNA CTD PMID:18198479 CBR1 Human pirinixic acid multiple interactions ISO Cbr1 (Mus musculus) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CBR1 mRNA and PPARA protein promotes the reaction [pirinixic acid results in increased expression of CBR1 mRNA] CTD PMID:19710929 and PMID:20059764 CBR1 Human pirinixic acid affects expression ISO Cbr1 (Rattus norvegicus) 6480464 pirinixic acid affects the expression of CBR1 mRNA CTD PMID:19483382 CBR1 Human pirinixic acid increases expression ISO Cbr1 (Rattus norvegicus) 6480464 pirinixic acid results in increased expression of CBR1 mRNA CTD PMID:19162173 and PMID:22484513 CBR1 Human pirinixic acid increases expression ISO Cbr1 (Mus musculus) 6480464 pirinixic acid results in increased expression of CBR1 mRNA CTD PMID:18301758 more ... CBR1 Human potassium chromate increases expression EXP 6480464 potassium chromate(VI) results in increased expression of CBR1 mRNA CTD PMID:22714537 CBR1 Human propiconazole increases expression ISO Cbr1 (Mus musculus) 6480464 propiconazole results in increased expression of CBR1 mRNA CTD PMID:21278054 CBR1 Human quercetin multiple interactions EXP 6480464 [Quercetin co-treated with NADP] binds to CBR1 protein more ... CTD PMID:11306090 more ... CBR1 Human rac-lactic acid decreases expression EXP 6480464 Lactic Acid results in decreased expression of CBR1 mRNA CTD PMID:30851411 CBR1 Human Rebamipide increases expression ISO Cbr1 (Rattus norvegicus) 6480464 rebamipide results in increased expression of CBR1 mRNA CTD PMID:18299717 CBR1 Human resveratrol multiple interactions ISO Cbr1 (Mus musculus) 6480464 Resveratrol inhibits the reaction [titanium dioxide results in increased expression of CBR1 mRNA] CTD PMID:31298478 CBR1 Human resveratrol affects binding EXP 6480464 CBR1 protein binds to resveratrol CTD PMID:24064738 CBR1 Human resveratrol multiple interactions EXP 6480464 [resveratrol results in decreased activity of CBR1 protein] which affects the susceptibility to Doxorubicin more ... CTD PMID:24064738 and PMID:24975222 CBR1 Human rotenone increases expression ISO Cbr1 (Rattus norvegicus) 6480464 Rotenone results in increased expression of CBR1 mRNA CTD PMID:28374803 CBR1 Human rutin multiple interactions EXP 6480464 Rutin binds to and results in decreased activity of CBR1 protein and Rutin inhibits the reaction [CBR1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] CTD PMID:11306090 and PMID:18579125 CBR1 Human S-nitrosoglutathione multiple interactions EXP 6480464 [S-Nitrosoglutathione binds to CBR1 protein] inhibits the reaction [CBR1 protein results in increased metabolism of 1 more ... CTD PMID:21256830 and PMID:23295225 CBR1 Human S-nitrosoglutathione increases reduction EXP 6480464 CBR1 protein results in increased reduction of S-Nitrosoglutathione CTD PMID:21256830 CBR1 Human SB 431542 multiple interactions EXP 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 and PMID:37664457 CBR1 Human sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of CBR1 mRNA CTD PMID:28595984 and PMID:34032870 CBR1 Human sodium arsenite decreases expression ISO Cbr1 (Rattus norvegicus) 6480464 sodium arsenite results in decreased expression of CBR1 protein CTD PMID:29459688 CBR1 Human sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of CBR1 mRNA CTD PMID:38568856 CBR1 Human sodium arsenite multiple interactions EXP 6480464 [sodium arsenite results in increased abundance of arsenite] which results in increased expression of CBR1 mRNA CTD PMID:32076005 CBR1 Human sodium chloride multiple interactions EXP 6480464 [Sodium Chloride co-treated with pyrogallol 1 and 3-dimethyl ether] results in decreased expression of and affects the localization of CBR1 protein CTD PMID:38598786 CBR1 Human sodium dichromate decreases expression ISO Cbr1 (Mus musculus) 6480464 sodium bichromate results in decreased expression of CBR1 mRNA CTD PMID:22155349 CBR1 Human sophoraflavanone B multiple interactions EXP 6480464 8-prenylnaringenin inhibits the reaction [CBR1 protein results in increased metabolism of Daunorubicin] more ... CTD PMID:30849340 CBR1 Human streptozocin decreases activity ISO Cbr1 (Rattus norvegicus) 6480464 Streptozocin results in decreased activity of CBR1 protein CTD PMID:11057757 CBR1 Human sulfasalazine decreases expression ISO Cbr1 (Rattus norvegicus) 6480464 Sulfasalazine results in decreased expression of CBR1 protein CTD PMID:15928459 CBR1 Human T-2 toxin affects expression ISO Cbr1 (Rattus norvegicus) 6480464 T-2 Toxin affects the expression of CBR1 protein CTD PMID:26141394 CBR1 Human tebufenpyrad decreases expression EXP 6480464 4-chloro-N-((4-(1 and 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of CBR1 mRNA CTD PMID:33512557 CBR1 Human testosterone multiple interactions ISO Cbr1 (Rattus norvegicus) 6480464 [bisphenol A co-treated with Testosterone] results in increased expression of CBR1 mRNA CTD PMID:26496021 CBR1 Human testosterone enanthate affects expression EXP 6480464 testosterone enanthate affects the expression of CBR1 mRNA CTD PMID:17440010 CBR1 Human tetrachloroethene increases expression ISO Cbr1 (Mus musculus) 6480464 Tetrachloroethylene results in increased expression of CBR1 mRNA CTD PMID:28973375 CBR1 Human tetrachloromethane increases expression ISO Cbr1 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of CBR1 mRNA CTD PMID:27339419 CBR1 Human tetrachloromethane increases expression ISO Cbr1 (Rattus norvegicus) 6480464 Carbon Tetrachloride results in increased expression of CBR1 mRNA CTD PMID:30723492 and PMID:31150632 CBR1 Human tetrachloromethane multiple interactions ISO Cbr1 (Rattus norvegicus) 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CBR1 mRNA] CTD PMID:31150632 CBR1 Human tetrachloromethane affects expression ISO Cbr1 (Mus musculus) 6480464 Carbon Tetrachloride affects the expression of CBR1 mRNA CTD PMID:31919559 CBR1 Human thalidomide decreases expression ISO Cbr1 (Mus musculus) 6480464 Thalidomide results in decreased expression of CBR1 mRNA CTD PMID:26217789 CBR1 Human thapsigargin increases expression ISO Cbr1 (Rattus norvegicus) 6480464 Thapsigargin results in increased expression of CBR1 protein CTD PMID:35544339 CBR1 Human thioacetamide affects expression ISO Cbr1 (Rattus norvegicus) 6480464 Thioacetamide affects the expression of CBR1 mRNA CTD PMID:19483382 CBR1 Human thioacetamide increases expression ISO Cbr1 (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of CBR1 mRNA CTD PMID:23411599 and PMID:34492290 CBR1 Human tiaprofenic acid increases reduction EXP 6480464 CBR1 protein results in increased reduction of tiaprofenic acid CTD PMID:28322780 CBR1 Human titanium dioxide increases expression ISO Cbr1 (Mus musculus) 6480464 titanium dioxide results in increased expression of CBR1 mRNA CTD PMID:23131501 and PMID:31298478 CBR1 Human titanium dioxide decreases methylation ISO Cbr1 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of CBR1 gene CTD PMID:35295148 CBR1 Human titanium dioxide multiple interactions ISO Cbr1 (Mus musculus) 6480464 Resveratrol inhibits the reaction [titanium dioxide results in increased expression of CBR1 mRNA] CTD PMID:31298478 CBR1 Human triclosan multiple interactions EXP 6480464 [Triclosan co-treated with NADP] binds to CBR1 protein CTD PMID:25526675 CBR1 Human undecane increases expression ISO Cbr1 (Rattus norvegicus) 6480464 undecane results in increased expression of CBR1 protein CTD PMID:17337753 CBR1 Human valdecoxib increases expression ISO Cbr1 (Rattus norvegicus) 6480464 valdecoxib results in increased expression of CBR1 mRNA CTD PMID:24136188 CBR1 Human valproic acid affects expression ISO Cbr1 (Mus musculus) 6480464 Valproic Acid affects the expression of CBR1 mRNA CTD PMID:17292431 CBR1 Human valproic acid multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CBR1 mRNA CTD PMID:27188386 CBR1 Human valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of CBR1 mRNA CTD PMID:23179753 more ... CBR1 Human valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of CBR1 mRNA CTD PMID:25979313 CBR1 Human valproic acid decreases methylation EXP 6480464 Valproic Acid results in decreased methylation of CBR1 gene CTD PMID:29154799 CBR1 Human vancomycin increases expression ISO Cbr1 (Mus musculus) 6480464 Vancomycin results in increased expression of CBR1 mRNA CTD PMID:18930951 CBR1 Human xanthohumol multiple interactions EXP 6480464 xanthohumol inhibits the reaction [CBR1 protein results in increased metabolism of Daunorubicin] more ... CTD PMID:30849340 CBR1 Human zearalenone decreases expression ISO Cbr1 (Mus musculus) 6480464 Zearalenone results in decreased expression of CBR1 protein CTD PMID:36252740 CBR1 Human zoledronic acid decreases expression EXP 6480464 zoledronic acid results in decreased expression of CBR1 mRNA CTD PMID:24714768
